Physiomics Plc (PYC) - Financial and Strategic SWOT Analysis Review

Physiomics Plc (PYC) - Financial and Strategic SWOT Analysis Review

  • Products Id :- GDPH82670FSA
  • |
  • Pages: 47
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Physiomics Plc (PYC)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.


Physiomics plc (Physiomics) is a computational systems biology services company. It offers Virtual Tumour, which optimizes the dosing and scheduling of oncology drugs in pre-clinical trials, cardiac toxicity services through its EasyAP, a Web-based simulation and analysis tool. It also offers model based drug development services, which includes population PKPD analysis of clinical data, back-translational analysis, optimal design of future studies. It is involved in developing outsourced systems and computational systems biology models for predicting and understanding cancer drug efficacy from pre-clinical research to clinical development and finding optimal schedules. The company provides consulting services for specific pharmaceutical development projects and provides trouble-shooting services for cancer projects. Physiomics partners with small and large pharmaceutical and biotechnology companies. Physiomics is headquartered at Oxford, England, the UK.

Physiomics Plc Key Recent Developments

Oct 08,2018: Physiomics: Final Results for the year ended 30 June 2018

Aug 09,2018: Physiomics signs agreement with new european biotech client

Jul 02,2018: Physiomics expands technical team

Apr 04,2018: Physiomics to Present at the American Association for Cancer Research ("AACR") Annual Meeting

Mar 14,2018: Physiomics: Award of New Innovate UK Grant

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

Physiomics Plc-Key Facts 5

Physiomics Plc-Key Employees 6

Physiomics Plc-Key Employee Biographies 7

Physiomics Plc-Major Products and Services 8

Physiomics Plc-History 9

Physiomics Plc-Company Statement 12

Physiomics Plc-Locations And Subsidiaries 13

Head Office 13

Section 2-Company Analysis 14

Company Overview 14

Physiomics Plc-Business Description 15

Physiomics Plc-Corporate Strategy 16

Physiomics Plc-SWOT Analysis 17

SWOT Analysis-Overview 17

Physiomics Plc-Strengths 17

Physiomics Plc-Weaknesses 18

Physiomics Plc-Opportunities 19

Physiomics Plc-Threats 20

Physiomics Plc-Key Competitors 21

Section 3-Company Financial Ratios 22

Financial Ratios-Capital Market Ratios 22

Financial Ratios-Annual Ratios 23

Performance Chart 25

Financial Performance 25

Financial Ratios-Interim Ratios 26

Financial Ratios-Ratio Charts 27

Section 4-Company's Lifesciences Financial Deals and Alliances 28

Physiomics Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28

Physiomics Plc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 29

Physiomics Plc, Recent Deals Summary 30

Section 5-Company's Recent Developments 31

Oct 08, 2018: Physiomics: Final Results for the year ended 30 June 2018 31

Aug 09, 2018: Physiomics signs agreement with new european biotech client 33

Jul 02, 2018: Physiomics expands technical team 34

Apr 04, 2018: Physiomics to Present at the American Association for Cancer Research ("AACR") Annual Meeting 35

Mar 14, 2018: Physiomics: Award of New Innovate UK Grant 36

Mar 12, 2018: Physiomics: Completion of Innovate UK Grant Project on Personalised Treatment of Oesophageal Cancer 37

Feb 19, 2018: Physiomics: Interim Results Statement for the six-month period ended 31 December 2017 38

Feb 09, 2018: Physiomics secures third major pharmaceutical client in matter of months 40

Jan 26, 2018: Physiomics: New Major Pharmaceutical Client 41

Nov 28, 2017: Completion of VT Clinical Project with Merck and announcement of Master Services Agreement 42

Section 6-Appendix 43

Methodology 43

Ratio Definitions 43

About GlobalData 47

Contact Us 47

Disclaimer 47

List of Figures

Physiomics Plc, Performance Chart (2014-2018) 25

Physiomics Plc, Ratio Charts 27

Physiomics Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28

Physiomics Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 29

List of Tables

Physiomics Plc, Key Facts 5

Physiomics Plc, Key Employees 6

Physiomics Plc, Key Employee Biographies 7

Physiomics Plc, Major Products and Services 8

Physiomics Plc, History 9

Physiomics Plc, Key Competitors 21

Physiomics Plc, Ratios based on current share price 22

Physiomics Plc, Annual Ratios 23

Physiomics Plc, Annual Ratios (Cont...1) 24

Physiomics Plc, Interim Ratios 26

Physiomics Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28

Physiomics Plc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 29

Physiomics Plc, Recent Deals Summary 30

Currency Codes 43

Capital Market Ratios 43

Equity Ratios 44

Profitability Ratios 44

Cost Ratios 45

Liquidity Ratios 45

Leverage Ratios 46

Efficiency Ratios 46

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@]

Elekta AB

Cyprotex Ltd

Gunsynd Plc

Avacta Group Plc

e-Therapeutics Plc

Sareum Holdings Plc

Physiomics Plc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license
Single User License
USD 125 INR 8578
Site License
USD 250 INR 17155
Corporate User License
USD 375 INR 25733



The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@]